appliedclinicaltrialsonline10h
Tecentriq Falls Short in Phase III Trial in Post-Surgery Triple-Negative Breast Cancer Patients
In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve treatment outcomes for patients with high-risk early-stage triple-negative ...
healthday11h
Weight Gain Common in Young Women After Breast Reduction Surgery
Many young women gain weight in the years after breast reduction surgery, according to a study published online in th ...
Hosted on MSN12h
Mayor Arceneaux on: Progress of 50 Cent & G-Unit Studios, Shreveport's water woes, crime reduction
The NBC 6 News Team presents a morning newscast featuring local and national events, along with weather and traffic updates ...
Breast Reduction Can Spur Weight Gain in Young Women
THURSDAY, Feb. 6, 2025 (HealthDay News) -- Many women may opt for a breast reduction if they encounter issues such as ...
Medscape19h
Which Treatment for Breast Cancer Results in Better QoL?
Compared with endocrine therapy, radiotherapy was associated with a smaller reduction in health-related quality-of-life in ...